CLINICAL_TRIALS
trial_result
· 2012-09-11
Clinical Trial Update: Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder [Phase 3]
Summary
Phase 3 trial results evaluating atomoxetine for attention-deficit/hyperactivity disorder in Asian adults have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2012-09-11